
Abeona’s Third Gene Therapy Program to Receive FDA Orphan Designation EB-101 Gene Therapy for ...

WALTHAM, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

Helsinn Group supports Satellite Symposium at 10th International Conference on Cachexia, Sarcopenia and Muscle ...
Click to continue to site. Closing